Remimazolam for sedation after non-cardiac surgery
Treatments studied
Part of Brain & nervous system, Heart & circulation, Lungs & breathing clinical trials.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are scheduled for a planned non-cardiac surgery with general anesthesia.
- After surgery, you will be in the ICU with a breathing tube and need the breathing machine for more than 24 hours.
- You need light sedation (RASS score 0 to -2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the anesthesia medicine remimazolam can improve recovery and longer-term outcomes after surgery for early-stage bladder cancer. If you are having a bladder tumor procedure through the urethra, this study may help doctors understand whether this anesthesia choice matters for prognosis.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
Hear when a new Adverse Drug Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.